VERWENDUNG KARDIOTONISCHER STEROIDEN ALS NA/K- ATPASE LIGANDEN ZUR HAUTBEHANDLUNG

摘要

This process relates to a pharmaceutical composition of an Na—K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. In another embodiment, the composition may be used to inhibit cardiac fibrosis.